Our great team!! 🥰🥰🥰🥰🥰

Excited to share this great work by Caroline Warly Solsberg Stefanie Piña Nick Cochran, PhD 🤩 🧬!!

Proudly pink-nailed #WomenInScience can be taken seriously (esp with beautiful figures by Caroline Warly Solsberg) thank you for your support of this important work with LAC-CD - @nih The Rainwater Charitable Foundation Alzheimer's Association Global Brain Health Institute #ISFTDMeeting

Check out our preprint on phenotyping Alzheimer's and sex differences in the EMR! medrxiv.org/content/10.110…. I presented this work at AMIA #IS21. Marina Sirota tomiko oskotsky Dena Dubal Zicheng Hu Caroline Warly Solsberg

Analysis of Y Chromosome Haplogroups in Parkinson's Disease medrxiv.org/cgi/content/sh… #medRxiv

Multi-ancestry meta-analysis + heterogeneity of risk loci / PRS in #Alzheimers #GWAS studies. Two of the funnest junior leads to work with #JulieLake and Caroline Warly Solsberg. Thanks @HamptonLLeonard for repping NIH Intramural's #CARD and leading. One of my favorite figures in this paper.

@ABindoff Maarten van Smeden Yeah, we tried to publish this little gem in a "real" journal but editors told us "everyone knows this already." biorxiv.org/content/10.110…

Excited to share our first scRNA-seq report on peripheral blood cells in familial tauopathy. Daniel Sirkis and Caroline Warly Solsberg co-led this story that highlights the opportunity for blood-based transcriptomic biomarkers in tauopathy. UCSF MAC PSPG@UCSF 💊🧬 #womeninSTEM biorxiv.org/content/10.110…

Very solid work Caroline Warly Solsberg and Jennifer Yokoyama 🦾!

Spreading the word for Lindsay Hohsfield — I am not affiliated with this group but it looks like a great opportunity for those impacted by genetic ALS & FTD. Feel free to RT to spread the word to your networks! Caroline Warly Solsberg Iris Broce UCSF MAC The Rainwater Charitable Foundation

I am thrilled to announce the launch of npj Dementia, for which I will be serving as the Editor-in-Chief. npj Dementia will be fully-open access and publish research that advances the field towards effective disease interventions. (1/3)